Kara M. Kelly

Multimodality Artificial Intelligence for Involved-Site Radiation Therapy: Clinical Target Volume Delineation in High-Risk Pediatric Hodgkin Lymphoma

Xin Tie, Sarah A. Milgrom, Andrea Lo, Anne-Marie Charpentier et autres

us, ca (code pays fourni par la source)

Tumor-Specific Immune Responses and Biomarkers in pediatric High-Risk Hodgkin Lymphoma Patients

Keri Toner, Lindsay A. Renfro, Hema Dave, G. Pezzella et autres

us, qa (code pays fourni par la source)

Enhancing Radiotherapy Quality Assurance in Lymphoma: A Rigorous Real-Time Central Review Process in AHOD2131

Andrea Lo, Sarah A. Milgrom, Raymond B. Mailhot Vega, Darren Hodgson et autres

ca, us (code pays fourni par la source)

Multi-modality Artificial Intelligence for Involved-Site Radiation Therapy: Clinical Target Volume Delineation in High-Risk Pediatric Hodgkin Lymphoma

Xin Tie, Sarah A. Milgrom, Andrea Lo, AM Charpentier et autres

us, ca (code pays fourni par la source)

Scientific update from the Global NLPHL One Working Group (GLOW)

Michael Palese, Ranjana H. Advani, Suzi Birz, Graham P. Collins et autres

us, gb (code pays fourni par la source)

Predicted Breast Cancer Risk after Mediastinal Radiotherapy for Pediatric Hodgkin Lymphoma: Analysis of a Multi-Institutional Children’s Oncology Group Trial

Sarah A. Milgrom, Harald Paganetti, Hitesh Dama, Lindsay A. Renfro et autres

us, ca, ch (code pays fourni par la source)

Survival By Race/Ethnicity in Children and Adolescents/Young Adults with Relapsed/Refractory Hodgkin Lymphoma: A Pooled Analysis of Children's Oncology Group Trials

Mallorie B. Heneghan, Lindsay A. Renfro, Yue Wu, Tanya Trippett et autres

us, ch (code pays fourni par la source)

Prognostic value of 18F-FDG PET/CT volumetric parameters in childhood, adolescent, and young adult Hodgkin lymphoma (CAYAHL): a systematic review from the international SEARCH group (Staging, Evaluation and Response Criteria Harmonization)

Claire Gowdy, Jamie E. Flerlage, Jennifer Seelisch, Michael Palese et autres

ca, us, at, de, it (code pays fourni par la source)

AHOD2131: A Randomized Phase 3 Response-Adapted Trial Comparing Standard Therapy to Immuno-oncology for Children & Adults with Newly Diagnosed Stage I and II Hodgkin Lymphoma

Jennifer Seelisch, Boyu Hu, Lindsay A. Renfro, Frank G. Keller et autres

ca, us, ch (code pays fourni par la source)

Hodgkin Lymphoma involving the CNS: An AHOD1331, PHL-C1 and PHL-C2 Report from the Children's Oncology Group and the European Network for Pediatric Hodgkin Lymphoma

Reena Pabari, Kathleen M. McCarten, Jamie E. Flerlage, Hollie Lai et autres

ca, us, de, at (code pays fourni par la source)

Supplementary Figure 1 from Treatment-Related Changes in Cerebrospinal Fluid Markers of Oxidative Stress and Neurodegeneration during Therapy for Childhood Acute Lymphoblastic Leukemia

Yongkyu Park, Nirajan K. C, Jérèmy Willekens, Chadni Patel et autres

Data from Treatment-Related Changes in Cerebrospinal Fluid Markers of Oxidative Stress and Neurodegeneration during Therapy for Childhood Acute Lymphoblastic Leukemia

Yongkyu Park, Nirajan K. C, Jérèmy Willekens, Chadni Patel et autres